In recent years, there has been increasing emphasis on the importance of mental health. Depression is one of the leading causes of disability, and suicide is the second leading cause of death among 15 to 29 year-olds. People with severe mental health conditions die prematurely as much as two decades early due to preventable conditions.
Topics: MedTech / HealthTech / BioTech
Industry: Health and BioMedical Sciences
Here in Singapore, we love our food, and we cannot lie. With many dishes and flavours from all corners of the world, it’s no wonder eating is the (unofficial) Singapore’s favourite pastime. As we continue to enjoy the latest food trends and culinary recipes, it’s essential that we not ignore the growing concern over our food supply.
Topics: MedTech / HealthTech / BioTech, Deep Tech for Good, Sustainability
Industry: AgriFood
Bioprinting is a process that is similar to 3D printing, with the key difference being the material used to print the product. Instead of utilising plastic or synthetic material, bioprinting creates organic matter using “bio-ink”, usually a mixture of cell types collected from a patient. Although this might at first sound like an overly futuristic process, bioprinting is, in reality, a rapidly advancing technology that scientists hope to advance to clinical trials within the next five to ten years.
Topics: MedTech / HealthTech / BioTech
Industry: Health and BioMedical Sciences
In Southeast Asia, healthcare expenditure is on the rise, with expectations that by 2025, total healthcare spending could increase to USD 740 billion from the current USD 425 billion. In addition, the growth of cost in healthcare per capita has outpaced the growth in GDP per capita in nearly all ASEAN countries, according to a report by corporate strategy consulting firm, Solidiance.
Topics: MedTech / HealthTech / BioTech, Startup and Corporate Open Innovation
Industry: Health and BioMedical Sciences
SGInnovate’s Corporate Pitch Event series brings together the community of corporates, CVCs and startups for thought leadership discussions, knowledge sharing and networking.
Topics: MedTech / HealthTech / BioTech, Investments, Startup and Corporate Open Innovation
Industry: Health and BioMedical Sciences
These days, devices such as smartphones and smartwatches are commonly used for daily step count but did you know that the way one walks- the gait, reveals a lot more than just one’s fitness? Gait reveals an individual’s identity as well as physical attributes such as height and age. As such, this identifier can be used to secure smart devices, provide personalised services, and perhaps even detect walking abnormalities.
Topics: AI / Machine Learning / Deep Learning, MedTech / HealthTech / BioTech
Industry: Health and BioMedical Sciences
Intellectual property is the lifeblood of the biotechnology industry. Strong patents are critical for biotechnology companies developing innovative solutions. For biotech startups, a well-thought-out patent strategy and having a plan for generating future intellectual property could be the deciding factor for its success.
Topics: MedTech / HealthTech / BioTech, Startup and Corporate Open Innovation
Like many other countries, Singapore faces evolving healthcare demands, driven by a rapidly ageing population and increased prevalence of chronic diseases. Precision Medicine (PM) is an innovative approach. Scientists and doctors consider the patient’s genetic background, lifestyle, and environmental factors to pre-empt the development of diseases and optimise treatments. The National Precision Medicine (NPM) programme is a whole-of-government approach to explore how PM should be best deployed in Singapore to drive research insights, clinical innovation, and economic growth. Through NPM, we hope to contribute to Singaporeans living healthier lives and its eventual impact across other Asian countries.
Topics: AI / Machine Learning / Deep Learning, MedTech / HealthTech / BioTech, MedTech / HealthTech / BioTech
Industry: Health and BioMedical Sciences
Like many other countries, Singapore faces evolving healthcare demands, driven by a rapidly ageing population and increased prevalence of chronic diseases. Precision Medicine (PM) is an innovative approach. Scientists and doctors consider the patient’s genetic background, lifestyle, and environmental factors to pre-empt the development of diseases and optimise treatments. The National Precision Medicine (NPM) programme is a whole-of-government approach to explore how PM should be best deployed in Singapore to drive research insights, clinical innovation, and economic growth. Through NPM, we hope to contribute to Singaporeans living healthier lives and its eventual impact across other Asian countries.
Topics: AI / Machine Learning / Deep Learning, MedTech / HealthTech / BioTech, MedTech / HealthTech / BioTech
Industry: Health and BioMedical Sciences
Regulatory science has always been the cornerstone of Translational Medicine (TM) and clinical development. It warrants safety, conformity with ethical and moral issues, and a balance between the need for innovation and the duty to preserve the patients' integrity and safety.
Topics: MedTech / HealthTech / BioTech, RegTech
Industry: Health and BioMedical Sciences
According to a report by the United Nations on World Population Prospects, it is estimated that by 2050, one in six people worldwide will be over the age of 65. However, in Singapore's context, one in four people will be over 65 by 2030 - exponentially earlier and higher than the global predicted average. With the worldwide population living longer lives, what are the ways science and technology can ensure an extended period of good or better health?
The COVID-19 pandemic has spurred innovations and research into improving the ageing experience for older adults. Find out from our experts as they share what it would take to be healthy for longer and to age in place by keeping one's independence in the comfort of one's home.
Topics: MedTech / HealthTech / BioTech
In response to the COVID-19 as the most pressing healthcare challenge of our time, the global science and technology innovation ecosystem has been collaborating and accelerating radical solutions to the pandemic and better meet the future's healthcare needs.
In Singapore, Deep Tech innovations have played a critical role to help manage the pandemic, such as Biofourmis’ AI-powered remote monitoring platform to detect early deterioration in COVID-19 patients, and also the Digital Health Passport, the first blockchain-powered solution to issue secure, tamper-proof digital COVID-19 medical records at scale with 100,000+ records issued and 4,000,000+ verifications performed. Similarly, health innovations across India have been growing fast in response to the COVID-19 pandemic. According to the “India’s Healthtech Landscape In A Post-Covid-19 World Report 2020” by DataLabs, the size of the HealthTech market in India is likely to increase to US$21 billion by 2025 from US$5.2 billion in 2019.
In this Leaders’ Dialogue, our industry leaders from Singapore and India will be discussing the impact of Deep Tech innovations on the future of healthcare and how startups, hospitals and other stakeholders may collaborate to accelerate the process.
Topics: AI / Machine Learning / Deep Learning, MedTech / HealthTech / BioTech